S. Quétant

1.1k total citations · 1 hit paper
19 papers, 536 citations indexed

About

S. Quétant is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, S. Quétant has authored 19 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in S. Quétant's work include Cystic Fibrosis Research Advances (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Transplantation: Methods and Outcomes (5 papers). S. Quétant is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Transplantation: Methods and Outcomes (5 papers). S. Quétant collaborates with scholars based in France, United States and Netherlands. S. Quétant's co-authors include Laurent Mély, Martine Reynaud‐Gaubert, I. Durieu, Dominique Grenet, R. Chiron, Lydie Lemonnier, Jennifer Da Silva, Christophe Marguet, Jean-Louis Paillasseur and Pierre‐Régis Burgel and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Scientific Reports and CHEST Journal.

In The Last Decade

S. Quétant

16 papers receiving 527 citations

Hit Papers

Rapid Improvement after Starting Elexacaftor–Tezacaftor–I... 2021 2026 2022 2024 2021 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease
    2021 148 citations Pierre‐Régis Burgel, I. Durieu et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Quétant France 11 339 90 89 71 67 19 536
Zuo Jun Xu China 12 221 0.7× 41 0.5× 87 1.0× 54 0.8× 53 0.8× 18 483
Nikos M. Siafakas Greece 14 364 1.1× 85 0.9× 165 1.9× 34 0.5× 61 0.9× 21 567
Bridget F. Collins United States 12 525 1.5× 65 0.7× 237 2.7× 40 0.6× 44 0.7× 27 703
Thomas A. Webb United States 10 103 0.3× 40 0.4× 71 0.8× 100 1.4× 130 1.9× 18 487
Claus Neurohr Germany 12 259 0.8× 113 1.3× 93 1.0× 133 1.9× 68 1.0× 44 567
Kathleen A. Young United States 9 130 0.4× 96 1.1× 62 0.7× 57 0.8× 23 0.3× 24 394
Michael Lazar United States 9 184 0.5× 63 0.7× 35 0.4× 62 0.9× 33 0.5× 17 368
Sumru Beder Türkiye 12 220 0.6× 35 0.4× 125 1.4× 99 1.4× 23 0.3× 28 428
Nathan Hambly Canada 14 412 1.2× 44 0.5× 200 2.2× 36 0.5× 35 0.5× 35 524
Yongjiang Tang China 11 146 0.4× 118 1.3× 46 0.5× 97 1.4× 71 1.1× 32 494

Countries citing papers authored by S. Quétant

Since Specialization
Citations

This map shows the geographic impact of S. Quétant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Quétant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Quétant more than expected).

Fields of papers citing papers by S. Quétant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Quétant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Quétant. The network helps show where S. Quétant may publish in the future.

Co-authorship network of co-authors of S. Quétant

This figure shows the co-authorship network connecting the top 25 collaborators of S. Quétant. A scholar is included among the top collaborators of S. Quétant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Quétant. S. Quétant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Burgel, Pierre‐Régis, I. Durieu, R. Chiron, et al.. (2021). Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 204(1). 64–73. 148 indexed citations breakdown →
2.
Choi, Bina, Jonathan Messika, Andrew Courtwright, et al.. (2021). Airway complications in lung transplant recipients with telomere‐related interstitial lung disease. Clinical Transplantation. 36(3). e14552–e14552. 10 indexed citations
3.
Camara, B., et al.. (2020). Rheological analysis of sputum from patients with chronic bronchial diseases. Scientific Reports. 10(1). 15685–15685. 45 indexed citations
4.
Quétant, S., et al.. (2019). Sélection des candidats à la transplantation pulmonaire en France en 2019. Revue des Maladies Respiratoires. 36(4). 508–518. 3 indexed citations
5.
Chanoine, Sébastien, et al.. (2018). Effets d’un accompagnement en activités physiques adaptées (APA) supervisé à domicile chez des patients atteints de mucoviscidose. Science & Sports. 33. S28–S29. 1 indexed citations
6.
Claustre, Johanna, et al.. (2018). Favorable Evolution of Cryptococcal Meningitis in the Context of Flucytosine Resistance.. Experimental and Clinical Transplantation. 16(1). 110–113.
7.
Fuchs, Andreas, José Carlos Benítez, S. Quétant, et al.. (2018). WS08.6 Effects of home-based adapted physical activity in patients with cystic fibrosis: an interventional study. Journal of Cystic Fibrosis. 17. S16–S16. 1 indexed citations
8.
Reynaud, Quitterie, Muriel Rabilloud, Sylvain Roche, et al.. (2017). Glucose trajectories in cystic fibrosis and their association with pulmonary function. Journal of Cystic Fibrosis. 17(3). 400–406. 12 indexed citations
9.
Chanoine, Sébastien, et al.. (2017). DI-087 Restrictive allograft syndrome in lung transplantation: nintedanib as a new therapeutic strategy?. A152.1–A152. 2 indexed citations
10.
Chanoine, Sébastien, et al.. (2017). DI-086 Interstitial lung disease induced by infliximab: a case report. A151.3–A152.
11.
Decorte, Nicolas, Mathieu Gruet, B. Camara, et al.. (2016). Absence of calf muscle metabolism alterations in active cystic fibrosis adults with mild to moderate lung disease. Journal of Cystic Fibrosis. 16(1). 98–106. 12 indexed citations
12.
Quétant, S., et al.. (2016). Intensité des soins lors des exacerbations et des complications des pathologies respiratoires chroniques. Revue des Maladies Respiratoires. 34(2). 102–120.
13.
Gruet, Mathieu, Nicolas Decorte, Laurent Mély, et al.. (2015). Skeletal muscle contractility and fatigability in adults with cystic fibrosis. Journal of Cystic Fibrosis. 15(1). e1–e8. 40 indexed citations
14.
Claustre, Johanna, S. Quétant, Pierrick Bedouch, et al.. (2014). Nonspecific Immunoglobulin Replacement in Lung Transplantation Recipients With Hypogammaglobulinemia. Transplantation. 99(2). 444–450. 10 indexed citations
15.
Bedouch, Pierrick, Matthieu Roustit, S. Quétant, et al.. (2011). Development of a pharmacist collaborative care program for pulmonary arterial hypertension. International Journal of Clinical Pharmacy. 33(6). 898–901. 5 indexed citations
16.
Toffart, Anne‐Claire, Clémence Minet, Bruno Raynard, et al.. (2010). Use of Intensive Care in Patients With Nonresectable Lung Cancer. CHEST Journal. 139(1). 101–108. 59 indexed citations
17.
Baillet, Athan, Candice Trocmé, Sylvie Berthier, et al.. (2010). Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Lara D. Veeken. 49(4). 671–682. 99 indexed citations
18.
Reynaud‐Gaubert, Martine, Jean‐François Mornex, Hervé Mal, et al.. (2008). Lung Transplantation for Lymphangioleiomyomatosis: The French Experience. Transplantation. 86(4). 515–520. 53 indexed citations
19.
Lantuéjoul, Sylvie, et al.. (2007). Unusual cystic presentation of pulmonary nodular amyloidosis associated with MALT-type lymphoma. European Respiratory Journal. 30(3). 589–592. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zuo Jun Xu Breakdown of academic impact, for papers by Nikos M. Siafakas Breakdown of academic impact, for papers by Bridget F. Collins Breakdown of academic impact, for papers by Thomas A. Webb Breakdown of academic impact, for papers by Claus Neurohr Breakdown of academic impact, for papers by Kathleen A. Young Breakdown of academic impact, for papers by Michael Lazar Breakdown of academic impact, for papers by Sumru Beder Breakdown of academic impact, for papers by Nathan Hambly Breakdown of academic impact, for papers by Yongjiang Tang
Rankless by CCL
2026